Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MELA Sciences Issues Statement on FDA's New Draft Guidance on Pivotal Clinical Trials
MELA Sciences Issues Statement on FDA's New Draft Guidance on Pivotal Clinical Trials
MELA Sciences Issues Statement on FDA's New Draft Guidance on Pivotal Clinical Trials
Submitted by
moderatorj
on August 17, 2011 - 10:26pm
Source:
Yahoo/MarketWire
News Tags:
MELA Sciences
FDA
clinical trials
Headline:
MELA Sciences Issues Statement on FDA's New Draft Guidance on Pivotal Clinical Trials
Do Not Allow Advertisers to Use My Personal information
